# GenSci144 Tablets Phase I Clinical Trial

> **NCT07685210** · PHASE1 · RECRUITING · sponsor: **Changchun GeneScience Pharmaceutical Co., Ltd.** · enrollment: 48 (estimated)

## Conditions studied

- Phenylketonuria

## Interventions

- **DRUG:** GenSci144 tablets
- **DRUG:** GenSci144 placebo tablets

## Key facts

- **NCT ID:** NCT07685210
- **Lead sponsor:** Changchun GeneScience Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-22
- **Primary completion:** 2026-09
- **Final completion:** 2026-12
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07685210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07685210, "GenSci144 Tablets Phase I Clinical Trial". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07685210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*